Novartis International AG / Novartis announces AMG 334 significantly reduces patients' monthly migraine days in phase II study of chronic migraine prevention . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely...
Source : http://www.romandie.com/news/Novartis-Internationa...
Source : http://www.romandie.com/news/Novartis-Internationa...